PedAM
Pediatric Disease Annotations & Medicines
| Disease | dementia |
| Symptom | C0042373|vascular disease |
| Sentences | 25 |
| PubMedID- 24746081 | Risk factors and predictive factors of cognitive deterioration in patients of vascular cognitive impairment no dementia with subcortical ischemic vascular disease. |
| PubMedID- 21051671 | Conclusions: the anatomy of metabolic abnormalities in vascular disease with dementia suggests that, at least in some cases, dementia with vascular disease may be independent of ad. |
| PubMedID- 19951274 | A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease. |
| PubMedID- 20935035 | In addition, 82% had two or more pathological processes that were felt to contribute to dementia, including 35% with cerebrovascular disease and 26% with lewy body disease. |
| PubMedID- 23650246 | Objectives: this study aimed to further elucidate the biobehavioral mechanisms linking dementia caregiving with an increased cardiovascular disease risk. |
| PubMedID- 26218598 | Conclusion smaller volumes in specific brain regions considered to be early markers of dementia risk were associated with specific cardiovascular disease risk factors and cognitive deficits in a predominantly midlife multiethnic population-based sample. |
| PubMedID- 24860814 | Recent clinical-pathological studies have focused on cognitive impairment and increased risk of dementia in patients with cerebrovascular disease . |
| PubMedID- 22264400 | By analogy, if dementia results from long-term cardiovascular disease, then statins might be unable to benefit subjects once overt dementia is apparent. |
| PubMedID- 23146611 | Our objective was to investigate the association of midlife vascular disease risk factors with dementia death. |
| PubMedID- 22163247 | The 12 cases included 4 of the 7 ad patients and 7 of the 10 dementia patients with obvious cerebrovascular disease (svd + md; non-significant difference between the patient groups). |
| PubMedID- 24886432 | Accordingly, we examined the association of modifiable cardiovascular disease risk factors with dementia death. |
| PubMedID- 20714236 | Cognitive impairment predicts functional capacity in dementia-free patients with cardiovascular disease. |
| PubMedID- 23561676 | Under-provision of medical care for vascular diseases for people with dementia in primary care: a cross-sectional review. |
| PubMedID- 26402118 | Objective: investigate associations of cardiovascular diseases with different dementia disorders and determine their impact on mortality. |
| PubMedID- 24731867 | Hypertension is a major risk factor for cerebrovascular diseases, leading to vascular dementia and neurodegeneration. |
| PubMedID- 19485934 | The present review aims to provide a concise overview of the recent advances linking vascular disease with dementia (with a particular focus on ad) and to examine the evidence for efficacy, where possible, for utilising vascular pharmacotherapy as a treatment option for dementia. |
| PubMedID- 25061284 | T2dm has been thought to be associated with vascular diseases, eventually leading to vascular dementia, but recent studies have established that t2dm is also associated with alzheimer's disease (ad). |
| PubMedID- 24597507 | Cortical atrophy and brain vascular disease are both associated with dementia, but there are only limited pathological data on the association of brain vascular disease with cortical atrophy. |
| PubMedID- 26219595 | The main findings suggest that subcortical vascular disease with or without dementia exhibit a characteristic neuropsychological pattern of mental slowness and executive dysfunction and neurochemical deviations typical of white matter changes and disturbed blood-brain barrier function. |
| PubMedID- 23573223 | It is particularly weak in its ability to measure executive functions, such as abstract thinking, judgment, problem solving and perception, all of which are relevant to the type of dementia associated with vascular disease. |
| PubMedID- 24520876 | Found an undermedication for cardiovascular diseases in patients with dementia, especially a less frequent treatment with antithrombotic agents in stroke and beta-blockers in case of hypertension . |
| PubMedID- 23727937 | This protective effect of galanthamine may have therapeutic potential for preventing neuronal death following a stroke, and is presently relevant in a clinical context for patients with mixed or vascular dementia (resulting from vascular disease). |
| PubMedID- 20540726 | Considering simultaneously the main effects of socio-demographic characteristics and comorbidity in a logistic regression model, the prevalence of dementia is associated with age, cerebrovascular disease and other neurological disease. |
| PubMedID- 24974383 | dementia associated with cerebrovascular disease is common. |
| PubMedID- 21575878 | Methods: in a population-based longitudinal epidemiological study, we fit cox proportional hazard models to examine the risk of incident dementia and ad associated with self-reported vascular disease. |
Page: 1